Hepatitis Completed Phase 3 Trials for Cepeginterferon alfa-2B (DB12814)

Also known as: Hepatits / Hepatitis NOS / Hepatitis, unspecified / Hepatitis nonspecific / Nonspecific hepatitis

IndicationStatusPhase
DBCOND0013077 (Hepatitis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02103439An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected PatientsTreatment
NCT01889433An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis CTreatment